Primary Sjogren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia

被引:15
作者
Higashi, K
Matsuki, Y
Hidaka, T
Aida, S
Suzuki, K
Nakamura, H
机构
[1] Internal Medicine I, National Defense Medical College
[2] Clinical Pathology, National Defense Medical College
[3] Internal Medicine I, National Defense Medical College, Tokorozawa, Saitama, 359
关键词
Castleman's disease; hyaline-vascular type; Sjogren's syndrome; autoimmune idiopathic thrombocytopenia;
D O I
10.3109/03009749709065725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of primary Sjogren's syndrome complicated by hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia. This type of Castleman's disease was diagnosed by biopsy of a right axillary lymph node 7 years after the onset of Sjogren's syndrome. The specimen showed small hyaline-vascular lymphoid follicles and interfollicular capillary proliferation. Serum IL-6 was slightly increased, but systemic manifestations, such as fever or weight loss, were not present. Hyaline-vascular type of Castleman's disease should be considered a lymphoproliferative disorder associated with Sjogren's syndrome.
引用
收藏
页码:482 / 484
页数:3
相关论文
共 21 条
[1]  
BARTOLI E, 1980, AM J CLIN PATHOL, V73, P423
[2]  
BUIJS L, 1992, ACTA HAEMATOL-BASEL, V87, P160
[3]  
CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[4]  
2-4
[5]   MULTICENTRIC CASTLEMANS DISEASE AND KAPOSIS SARCOMA [J].
CHEN, KTK .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1984, 8 (04) :287-293
[6]  
FISHLEDER A, 1987, NEW ENGL J MED, V316, P118
[7]   A SYSTEMIC LYMPHOPROLIFERATIVE DISORDER WITH MORPHOLOGIC FEATURES OF CASTLEMANS DISEASE - PATHOLOGICAL FINDINGS IN 15 PATIENTS [J].
FRIZZERA, G ;
BANKS, PM ;
MASSARELLI, G ;
ROSAI, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (03) :211-231
[8]  
GABA AR, 1978, AM J CLIN PATHOL, V69, P86
[9]  
GITTINGER JW, 1989, OPHTHALMOLOGY, V96, P1646
[10]  
KELLER AR, 1972, CANCER-AM CANCER SOC, V29, P670, DOI 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO